Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20440754rdf:typepubmed:Citationlld:pubmed
pubmed-article:20440754lifeskim:mentionsumls-concept:C0001490lld:lifeskim
pubmed-article:20440754lifeskim:mentionsumls-concept:C0018561lld:lifeskim
pubmed-article:20440754lifeskim:mentionsumls-concept:C0008286lld:lifeskim
pubmed-article:20440754lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:20440754lifeskim:mentionsumls-concept:C0286079lld:lifeskim
pubmed-article:20440754lifeskim:mentionsumls-concept:C0598312lld:lifeskim
pubmed-article:20440754lifeskim:mentionsumls-concept:C1512656lld:lifeskim
pubmed-article:20440754pubmed:issue5lld:pubmed
pubmed-article:20440754pubmed:dateCreated2010-5-4lld:pubmed
pubmed-article:20440754pubmed:abstractTextAdenoviruses can cause severe toxicity in children and in immunocompromised adults, and therefore a means to abrogate replication would be useful. With regard to cancer treatment, replication competent oncolytic adenoviruses have been safe in humans, although their efficacy has been variable. Therefore, more effective agents are now entering clinical testing and, consequently, replication-associated side effects remain a concern. Preclinical analysis of replication related toxicity has been hampered by a lack of permissive models. Therefore, it has been difficult to study modulation of human adenovirus replication in immune competent animals.lld:pubmed
pubmed-article:20440754pubmed:languageenglld:pubmed
pubmed-article:20440754pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20440754pubmed:citationSubsetIMlld:pubmed
pubmed-article:20440754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20440754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20440754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20440754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20440754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20440754pubmed:statusMEDLINElld:pubmed
pubmed-article:20440754pubmed:monthMaylld:pubmed
pubmed-article:20440754pubmed:issn1521-2254lld:pubmed
pubmed-article:20440754pubmed:authorpubmed-author:KanervaAnnaAlld:pubmed
pubmed-article:20440754pubmed:authorpubmed-author:HemminkiAksel...lld:pubmed
pubmed-article:20440754pubmed:authorpubmed-author:CerulloVincen...lld:pubmed
pubmed-article:20440754pubmed:authorpubmed-author:BauerschmitzG...lld:pubmed
pubmed-article:20440754pubmed:authorpubmed-author:EscutenaireSo...lld:pubmed
pubmed-article:20440754pubmed:authorpubmed-author:Hernandez-Alc...lld:pubmed
pubmed-article:20440754pubmed:authorpubmed-author:DiaconuIuliaIlld:pubmed
pubmed-article:20440754pubmed:authorpubmed-author:PesonenSariSlld:pubmed
pubmed-article:20440754pubmed:copyrightInfoCopyright (c) 2010 John Wiley & Sons, Ltd.lld:pubmed
pubmed-article:20440754pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20440754pubmed:volume12lld:pubmed
pubmed-article:20440754pubmed:ownerNLMlld:pubmed
pubmed-article:20440754pubmed:authorsCompleteYlld:pubmed
pubmed-article:20440754pubmed:pagination435-45lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:meshHeadingpubmed-meshheading:20440754...lld:pubmed
pubmed-article:20440754pubmed:year2010lld:pubmed
pubmed-article:20440754pubmed:articleTitleHuman adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir.lld:pubmed
pubmed-article:20440754pubmed:affiliationCancer Gene Therapy Group, Molecular Cancer Biology Program & Transplantation Laboratory & Haartman Institute & Finnish Institute for Molecular Medicine, University of Helsinki, Haartmaninkatu 8, Helsinki, Finland.lld:pubmed
pubmed-article:20440754pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20440754pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20440754lld:pubmed